D

Delcath Systems

D
DCTH
USD
0
(0%)
Market Closed
29,187.00
Volume
-1.21
EPS
-
Div Yield
-4.345238
P/E
306,609,230.85
Market Cap
Today
0.0000%
1 Week
0.643%
1 Month
28.672%
6 Months
91.769%
12 Months
239.009%
Year To Date
163.855%
All Time
0%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news

Thailand's Economy Stumbles as Regional Peers Improve

04.04.2024
Economy news
More
Related Instruments
A
ADMP
(%)
USD
C
CRMD
0.34
(3.3074%)
USD
T
TXMD
0.01
(0.6494%)
USD

Title:
Delcath Systems

Sector:
Healthcare
Industry:
Medical Devices
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS,is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Do you need help or have a question?
Contact Us